Stay updated on AVANOVA: Niraparib vs Niraparib-bevacizumab in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the AVANOVA: Niraparib vs Niraparib-bevacizumab in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AVANOVA: Niraparib vs Niraparib-bevacizumab in Ovarian Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.1 to v3.4.2. This is a minor UI/metadata change with no impact on study details.
    Difference
    0.1%
    Check dated 2026-02-13T17:26:55.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.0 to v3.4.1. No changes to study content or eligibility criteria.
    Difference
    0.1%
    Check dated 2026-02-06T11:27:12.000Z thumbnail image
  4. Check
    20 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.1, replacing the previous Revision: v3.4.0. This is a minor template/version update that does not affect study details.
    Difference
    0.1%
    Check dated 2026-02-05T11:20:45.000Z thumbnail image
  5. Check
    27 days ago
    Change Detected
    Summary
    Added a Show glossary control and updated page metadata to Revision: v3.4.0. Removed older labels such as Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-29T06:28:21.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.3 to v3.3.4. No substantive changes to trial details are indicated.
    Difference
    0.1%
    Check dated 2026-01-15T03:17:03.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Locations sections were updated to include Massachusetts and Region Sjælland. The headings 'Massachusetts Locations' and 'Region Sjælland Locations' were removed and the page revision updated from v3.3.2 to v3.3.3.
    Difference
    0.3%
    Check dated 2025-12-24T14:59:12.000Z thumbnail image

Stay in the know with updates to AVANOVA: Niraparib vs Niraparib-bevacizumab in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AVANOVA: Niraparib vs Niraparib-bevacizumab in Ovarian Cancer Clinical Trial page.